ATE469175T1 - Prkcs als modifikatoren des beta catenin pfads und anwendungsverfahren - Google Patents
Prkcs als modifikatoren des beta catenin pfads und anwendungsverfahrenInfo
- Publication number
- ATE469175T1 ATE469175T1 AT04781103T AT04781103T ATE469175T1 AT E469175 T1 ATE469175 T1 AT E469175T1 AT 04781103 T AT04781103 T AT 04781103T AT 04781103 T AT04781103 T AT 04781103T AT E469175 T1 ATE469175 T1 AT E469175T1
- Authority
- AT
- Austria
- Prior art keywords
- beta catenin
- prkcs
- modifiers
- application method
- catenin pathway
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49517203P | 2003-08-14 | 2003-08-14 | |
| PCT/US2004/026361 WO2005016282A2 (en) | 2003-08-14 | 2004-08-13 | Prkcs as modifiers of the beta catenin pathway and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE469175T1 true ATE469175T1 (de) | 2010-06-15 |
Family
ID=34193286
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04781084T ATE482979T1 (de) | 2003-08-14 | 2004-08-12 | Ups als den beta-catenin-pfad modifizierende substanzen und anwendungsverfahren |
| AT04781103T ATE469175T1 (de) | 2003-08-14 | 2004-08-13 | Prkcs als modifikatoren des beta catenin pfads und anwendungsverfahren |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04781084T ATE482979T1 (de) | 2003-08-14 | 2004-08-12 | Ups als den beta-catenin-pfad modifizierende substanzen und anwendungsverfahren |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20080050313A1 (de) |
| EP (3) | EP1651674B1 (de) |
| JP (3) | JP2007502118A (de) |
| AT (2) | ATE482979T1 (de) |
| AU (3) | AU2004265662B2 (de) |
| CA (3) | CA2535897A1 (de) |
| DE (2) | DE602004029368D1 (de) |
| WO (3) | WO2005017119A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4606712B2 (ja) | 2003-01-08 | 2011-01-05 | マサチューセッツ インスティテュート オブ テクノロジー | ２−ｏスルファターゼ組成物および関連の方法 |
| CA2674493C (en) | 2007-01-05 | 2017-05-09 | Massachusetts Institute Of Technology | Compositions of and methods of using sulfatases from flavobacterium heparinum |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
| US4670388A (en) | 1982-12-30 | 1987-06-02 | Carnegie Institution Of Washington | Method of incorporating DNA into genome of drosophila |
| US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| GB9517780D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
| GB9517779D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
| WO1998042876A1 (en) | 1997-03-26 | 1998-10-01 | Board Of Regents, The University Of Texas System | Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| US6066500A (en) * | 1999-06-25 | 2000-05-23 | Isis Pharmaceuticals Inc. | Antisense modulation of Beta catenin expression |
| AU1086501A (en) | 1999-10-15 | 2001-04-30 | Carnegie Institution Of Washington | Rna interference pathway genes as tools for targeted genetic interference |
| AU2001236990A1 (en) * | 2000-02-14 | 2001-08-27 | Yale University | Compositions, methods and kits relating to uridine phosphorylase gene mutations |
| WO2001094629A2 (en) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
| US20020015943A1 (en) * | 2000-07-31 | 2002-02-07 | Mariann Bienz | Assays, methods and means relating to the modulation of levels of nuclear beta-catenin |
| US20020110841A1 (en) * | 2000-12-22 | 2002-08-15 | KUFE Donald W. | Regulation of cell growth by MUC1 |
| US20030087250A1 (en) * | 2001-03-14 | 2003-05-08 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| US7771931B2 (en) * | 2001-09-06 | 2010-08-10 | The General Hospital Corporation | Methods for diagnosing and treating diseases and conditions associated with protein kinase Cλ |
| WO2003052068A2 (en) * | 2001-12-13 | 2003-06-26 | Exelixis, Inc. | Mbcats as modifiers of the beta-catenin pathway and methods of use |
| US20040014049A1 (en) * | 2002-07-19 | 2004-01-22 | Isis Pharmaceuticals Inc. | Antisense modulation of protein kinase C-iota expression |
-
2004
- 2004-08-12 JP JP2006523402A patent/JP2007502118A/ja not_active Withdrawn
- 2004-08-12 DE DE602004029368T patent/DE602004029368D1/de active Active
- 2004-08-12 CA CA002535897A patent/CA2535897A1/en not_active Abandoned
- 2004-08-12 US US10/568,142 patent/US20080050313A1/en not_active Abandoned
- 2004-08-12 AU AU2004265662A patent/AU2004265662B2/en not_active Ceased
- 2004-08-12 EP EP04781084A patent/EP1651674B1/de active Active
- 2004-08-12 AT AT04781084T patent/ATE482979T1/de not_active IP Right Cessation
- 2004-08-12 CA CA002535901A patent/CA2535901A1/en not_active Abandoned
- 2004-08-12 WO PCT/US2004/026339 patent/WO2005017119A2/en active Application Filing
- 2004-08-12 JP JP2006523403A patent/JP2007502119A/ja active Pending
- 2004-08-12 WO PCT/US2004/026338 patent/WO2005017118A2/en active Application Filing
- 2004-08-12 EP EP04781083A patent/EP1654349A4/de not_active Withdrawn
- 2004-08-12 AU AU2004265661A patent/AU2004265661A1/en not_active Abandoned
- 2004-08-13 DE DE602004027387T patent/DE602004027387D1/de active Active
- 2004-08-13 CA CA002535812A patent/CA2535812A1/en not_active Abandoned
- 2004-08-13 WO PCT/US2004/026361 patent/WO2005016282A2/en active Application Filing
- 2004-08-13 AT AT04781103T patent/ATE469175T1/de not_active IP Right Cessation
- 2004-08-13 JP JP2006523407A patent/JP2007515935A/ja active Pending
- 2004-08-13 AU AU2004264952A patent/AU2004264952B2/en not_active Ceased
- 2004-08-13 EP EP04781103A patent/EP1653915B1/de active Active
- 2004-08-13 US US10/567,950 patent/US20070128606A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1651674B1 (de) | 2010-09-29 |
| EP1654349A4 (de) | 2008-08-20 |
| AU2004265662B2 (en) | 2010-12-16 |
| DE602004027387D1 (de) | 2010-07-08 |
| AU2004264952B2 (en) | 2010-12-16 |
| EP1651674A2 (de) | 2006-05-03 |
| JP2007502119A (ja) | 2007-02-08 |
| EP1654349A2 (de) | 2006-05-10 |
| EP1653915B1 (de) | 2010-05-26 |
| AU2004265662A1 (en) | 2005-02-24 |
| WO2005017118A2 (en) | 2005-02-24 |
| ATE482979T1 (de) | 2010-10-15 |
| CA2535901A1 (en) | 2005-02-24 |
| DE602004029368D1 (de) | 2010-11-11 |
| JP2007502118A (ja) | 2007-02-08 |
| AU2004265661A1 (en) | 2005-02-24 |
| WO2005017119A3 (en) | 2006-01-26 |
| CA2535897A1 (en) | 2005-02-24 |
| WO2005017118A3 (en) | 2006-07-06 |
| EP1653915A2 (de) | 2006-05-10 |
| EP1651674A4 (de) | 2006-09-20 |
| AU2004264952A1 (en) | 2005-02-24 |
| US20070128606A1 (en) | 2007-06-07 |
| WO2005016282A3 (en) | 2006-04-06 |
| EP1653915A4 (de) | 2007-09-05 |
| WO2005017119A2 (en) | 2005-02-24 |
| CA2535812A1 (en) | 2005-02-24 |
| WO2005016282A2 (en) | 2005-02-24 |
| US20080050313A1 (en) | 2008-02-28 |
| JP2007515935A (ja) | 2007-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE483976T1 (de) | Gfats als modifikatoren des p53-wegs und verwendungsverfahren | |
| WO2003083047A3 (en) | MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
| ATE489628T1 (de) | Galk1s als modifikatoren des pten/akt-wegs | |
| ATE536549T1 (de) | Galnts als modifikatoren des igfr-weges und verwendungsverfahren | |
| DE602005025737D1 (de) | C20orf23 als modifikator des igfr-wegs und verwendungsverfahren | |
| ATE469175T1 (de) | Prkcs als modifikatoren des beta catenin pfads und anwendungsverfahren | |
| WO2004024882A3 (en) | FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| ATE506614T1 (de) | Gfats als modifikatoren des axin-wegs und verwendungsverfahren | |
| WO2004005483A3 (en) | ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| WO2004015071A3 (en) | CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| WO2005052134A3 (en) | Ttbks as modifiers of the beta catenin pathway and methods of use | |
| WO2004015072A3 (en) | Mrbs as modifiers of the rb pathway and methods of use | |
| WO2005003305A3 (en) | Usps as modifiers of the beta catenin pathway and methods of use | |
| WO2004048541A3 (en) | Cct6s as modifiers of the rb pathway and methods of use | |
| WO2003074677A3 (en) | MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE | |
| WO2003074673A3 (en) | Lgals as modifiers of the chk pathway and methods of use | |
| WO2004083389A3 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
| WO2004104168A3 (en) | Mrbs as modifiers of the rb pathway and methods of use | |
| WO2004067721A3 (en) | Tkts as modifiers of the beta-catenin pathway and methods of use | |
| WO2004083447A3 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |